Stuart D. Russell, MD
Professor of Medicine
Duke University School of Medicine
Regional Director of Heart Failure
Duke University Medical Center
John J. Russell, MD
Clinical Professor of Family and Community Medicine
Thomas Jefferson University
Sydney Kimmel College of Medicine
Program Director, Family Medicine Residency Abington-Jefferson Health
0.5 AMA PRA Category 1 Credit™
Heart failure is common in the United States, affecting about 6.5 million adults. Although nearly 1 million new cases are diagnosed annually, delays in diagnosis are frequent. Patients who are at risk for heart failure do not often receive appropriate recommended testing. And when diagnosed, heart failure is often misclassified or not classified, which can lead to mismanagement. This activity will examine considerations for diagnosis and classification of heart failure in the primary care setting.
This educational activity is designed to meet the needs of primary care/internal medicine clinicians (including physicians, NPs, PAs, nurses).
Upon completion of this educational activity, the participant should be able to:
- Recognize patients who have risk factors for HF.
- Integrate testing into the decision-making process to diagnose chronic HF and acute HF.
- Summarize ACC/AHA and NYHA HF classification criteria.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine, asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME defines "relevant financial relationships" as financial relationships in any amount occurring within the past 12 months including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Dr. Stuart Russell discloses that he has served as a consultant for Abbott and Medtronic.
Dr. John Russell discloses that he has served as an advisor and speaker for Sanofi.
Mahira Zec Bonomo, University of Chicago, Director for CME, has nothing to disclose.
Kathleen Hines, MCM Education VP, Editorial Services, has nothing to disclose.
Lillian McVey, MCM Education Medical Writer, has nothing to disclose.
Faculty members are required to inform the audience when they are discussing off-label or unapproved uses of devices or drugs. Devices or drugs that are still undergoing clinical trials are identified as such and should not be portrayed as standard, accepted therapy. Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing physician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and MCM Education. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other health care professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credits™. from organizations accredited by the ACCME, please consult your professional licensing board.
Commercial Support Statements
This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.
Instructions for Credit
- Participation in this self-study activity should be completed in approximately 0.5 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from August 30, 2019, through August 30, 2020:
A. Register online at http://www.clinicaloptions.com.
B. Read the target audience, learning objectives, and faculty disclosures.
C. Study the educational activity online or printed out.
D. Submit answers to the posttest questions and evaluation questions online.
You must receive a test score of at least 80% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.
There is no charge for CME credit.
©2019 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, The University of Chicago Pritzker School of Medicine, or Novartis Pharmaceuticals Corporation. Any medications, diagnostic procedures, or treatments discussed by the program presenters should not be used by clinicians or other health care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.